stock.name

Bausch Health Companies Inc

BHC

Market Cap$2.59B
Close$

Compare Bausch Health Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bausch Health Companies IncBausch Health Companies Inc-5.70%41%0.3-19.8
marketMarket Avg53.21.27%29%-1.3
HealthcareHealthcare Avg29.71.32%16%7.31.3
$12.00

Target Price by Analysts

89% upsideBausch Health Companies Target Price DetailsTarget Price
$12.03

Current Fair Value

89.5% upside

Undervalued by 89.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.59 Billion
Enterprise Value$23.93 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.24
Beta1.1
Outstanding Shares366,796,721
Avg 30 Day Volume3,261,849

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.7
PEG8.36
Price to Sales0.26
Price to Book Ratio-1.59
Enterprise Value to Revenue2.67
Enterprise Value to EBIT14.31
Enterprise Value to Net Income-53
Total Debt to Enterprise0.92
Debt to Equity-19.8

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Bausch Health Companies Inc

21,100 employees

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...